Detalles de la búsqueda
1.
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Respir Res
; 23(1): 114, 2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35509077
2.
Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.
Pulm Pharmacol Ther
; 26(5): 555-61, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23524015
3.
Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects.
Alzheimer Dis Assoc Disord
; 27(3): 278-86, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-22922591
4.
Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial.
Hum Vaccin Immunother
; 19(1): 2187194, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36974988
5.
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial.
Vaccine
; 40(41): 5924-5932, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068109
6.
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
Lancet Respir Med
; 10(5): 435-446, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026180
7.
Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: 4-year follow-up of a phase 1 multicentre trial.
Vaccine X
; 9: 100124, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820619
8.
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.
Vaccine
; 37(41): 6102-6111, 2019 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447126
9.
Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
PLoS Negl Trop Dis
; 12(6): e0006340, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29874228
10.
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea--A randomised trial.
Vaccine
; 34(9): 1180-6, 2016 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26826544
11.
CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.
Curr Alzheimer Res
; 10(7): 742-53, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23968157
12.
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
Vaccine
; 30(23): 3470-7, 2012 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22446638
13.
Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults.
Vaccine
; 30(35): 5285-92, 2012 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22659448
14.
Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons.
Hum Vaccin Immunother
; 8(5): 645-52, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22418809
15.
Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.
Viral Immunol
; 25(3): 216-25, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22691101
16.
Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
J Infect Dis
; 200(6): 841-8, 2009 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19673651
Resultados
1 -
16
de 16
1
Próxima >
>>